IRDiRC

Client : ISERM ( Paris )

The International Rare Diseases Research Consortium (IRDiRC) was launched in April 2011 to foster international collaboration in rare diseases research. IRDiRC will team up researchers and organisations investing in rare diseases research in order to achieve two main objectives, namely to deliver 200 new therapies for rare diseases and means to diagnose most rare diseases by the year 2020.

watch the video

qián - IRDiRC
qián - IRDiRC
qián - IRDiRC
qián - IRDiRC
qián - IRDiRC
qián - IRDiRC
qián - IRDiRC
qián - IRDiRC
qián - IRDiRC